About Piramal Life Sciences
We are a research and innovation focused enterprise, uniquely engaged in developing novel healthcare solutions from natural sources such as plants. We follow stringent norms for standardisation, validation and product development, ensuring world class quality and consistent performance; thus applying the rigours of modern science to the goodness of natural medicine.
Piramal Life Sciences Limited (PLSL) is part of the over USD 1 billion Piramal Enterprises, one of India’s largest diversified business houses. The flagship company of the Group, Piramal Healthcare Limited recently sold its domestic formulations business to Abbott and is collaborating with companies like Eli Lilly and Merck, and premier institutes in India and abroad, for discovering and developing new drugs to treat unmet medical needs. The New Chemical Entity (NCE) Research unit of PLSL recently demerged from PLSL into Piramal Healthcare Limited and is now known as Piramal Healthcare Research.
News & Events
A revolutionary treatment for Psoriasis from Piramal Life Sciences
PLSL has discovered and developed a new medication (Tinefcon®) for psoriasis that works through a mechanism that is different from conventional drugs (steroids, immunosuppressants) yet is effective & safe. The efficacy & safety of Tinefcon® has been evaluated in three clinical trials, one of which was discussed at the recent conference of the American Association of Dermatology (AAD).